Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

Antibacterial activities of selected Cameroonian spices and their synergistic effects with antibiotics against multidrug-resistant phenotypes

  • Aimé G Fankam1,
  • Victor Kuete1Email author,
  • Igor K Voukeng1,
  • Jules R Kuiate1 and
  • Jean-Marie Pages2
BMC Complementary and Alternative MedicineThe official journal of the International Society for Complementary Medicine Research (ISCMR)201111:104

DOI: 10.1186/1472-6882-11-104

Received: 4 August 2011

Accepted: 1 November 2011

Published: 1 November 2011

Abstract

Background

The emergence of multi-drug resistant (MDR) phenotypes is a major public health problem today in the treatment of bacterial infections. The present study was designed to evaluate the antibacterial activities of the methanol extracts of eleven Cameroonian spices on a panel of twenty nine Gram negative bacteria including MDR strains.

Methods

The phytochemical analysis of the extracts was carried out by standard tests meanwhile the liquid micro-broth dilution was used for all antimicrobial assays.

Results

Phytochemical analysis showed the presence of alkaloids, phenols and tannins in all plants extracts. The results of the antibacterial assays indicated that all tested extracts exert antibacterial activities, with the minimum inhibitory concentration (MIC) values varying from 32 to 1024 μg/ml. The extracts from Dichrostachys glomerata, Beilschmiedia cinnamomea, Aframomum citratum, Piper capense, Echinops giganteus, Fagara xanthoxyloïdes and Olax subscorpioïdea were the most active. In the presence of efflux pump inhibitor, PAßN, the activity of the extract from D. glomerata significantly increased on 69.2% of the tested MDR bacteria. At MIC/5, synergistic effects were noted with the extract of D. glomerata on 75% of the tested bacteria for chloramphenicol (CHL), tetracycline (TET) and norfloxacin (NOR). With B. cinnamomea synergy were observed on 62.5% of the studied MDR bacteria with CHL, cefepime (FEP), NOR and ciprofloxacin (CIP) and 75% with erythromycin (ERY).

Conclusion

The overall results provide information for the possible use of the studied extracts of the spices in the control of bacterial infections involving MDR phenotypes.

Background

The emergence of MDR phenotypes is a major public health problem today in the treatment of bacterial infections. The multi-drug resistance of Gram negative bacteria is a major cause of morbidity and mortality in health care services [1]. The activation of bacterial efflux pumps also plays an important role in the appearance of resistance to antibiotics [2]. The real challenge for scientists worldwide today, is to continuously find new drugs to combat resistant microorganisms, or compounds which are able to inhibit the resistance mechanisms of pathogens, therefore restoring the activity of antibiotics. Medicinal plants are rich in compounds which may be potential natural drugs and serve as alternative, less expensive and safe antimicrobials for the treatment of common ailments. Plant drugs are widely used in Africa for the treatment of many ailments and constitute the first health recourse for about 80% of the population [3]. A number of pharmaceutical products in current use worldwide are derived from plants [4]. In Cameroon, many medicinal plants including spices are used as herbal medicines. The present work was therefore designed to investigate the antibacterial potential against MDR bacteria of some of the commonly used medicinal spices in Cameroon such as Fagara xantoxyloides Watern., Dichrostachys glomerata (Forsk) Chuov, Olax subscorpioïdea Oliv., Solanum melongeua L. Var inerme D.C Hiern, Piper capense Lin.f, Xylopia aethiopica Dunal A. Rich., Aframomum citratum (Pereira). Schum, Scorodophloeus zenkeri Harms., Beilschmiedia cinnamomea (Stapf) Robyns & Wilczek, Echinops giganteus A. Rich and Mondia whitei (Hook F). Skell. This study was also extended to the evaluation of the potencies of the above plant extracts to increase the activity of some antibiotics on MDR bacteria. The role of bacterial efflux pumps in resistance to the extracts was also studied.

Methods

Plant materials and extraction

The eleven edible spices used in this work were purchased from Dschang local market, West Region of Cameroon in January 2010. The collected spices materials were: the fruits of Fagara xanthoxyloides, Dichrostachys glomerata, Olax subscorpioïdea, Solanum melongeua, Piper capense and Xylopia aethiopica, the bark of Aframomum citratum, Scorodophloeus zenkeri, Beilschmiedia cinnamomea and the roots of Echinops giganteus and Mondia whitei. The plants were identified by Mr. Fulbert Tadjouteu of the National herbarium (Yaoundé, Cameroon) where voucher specimens were deposited under the reference numbers (Table 1).
Table 1

Spices used in the present study and evidence of their activities.

Spice samples (Family)

Herbarium Voucher numbera

Part used

Bioactive (or potentially active) compoundsb and screened activityc for crude plant extract

Fagara xanthozyloïdes

Watern. (Rutaceae)

21793/HNC/SRF

Fruits

Antimicrobial activity of essential oil [S: Ec, Bc, Bs, Af, Kp, Sa, Sf [19]; Cytotoxicity of fruits crude methanol extract [weak activity on leukemia CCRF-CEM and CEM/ADR5000 cells, and pancreatic MiaPaCa-2 cell lines] [27]

Dichrostachys glomerata

( Forsk) chuov (Mimosaceae)

15220/SRF-Cam

Bark, fruits

Cytotoxicity of roots crude methanol extract [weak activity on leukemia CCRF-CEM and CEM/ADR5000 cells, and pancreatic MiaPaCa-2 cell lines][27]

Aframomum citratum

(Pereira). Schum (Zingiberaceae)

37736/SRF-Cam

Leaves, fruits

Cytotoxicity of leaves crude methanol extract [weak activity on leukemia CCRF-CEM and CEM/ADR5000 cells, and pancreatic MiaPaCa-2 cell lines] [27]

Beilschmiedia cinnamomea (Stapf) Robyns & Wilczek (Lauraceae)

6933/SRF-Cam

Roots

/

Echinops giganteus

A. Rich. (Asteraceae)

23647/SRF-Cam

Rhizomes

Antimicrobial [lupeol sitosteryl; β-D-glucopyranoside] [2831]; Cytotoxicity of rhizome crude methanol extract [Significant activity with IC50 values of 6.68; 7.96 and 9.84 μg/ml respectively on leukemia CCRF-CEM cells, CEM/5000 cells and pancreatic MiaPaCa-2 cell lines] [27]

Mondia whitei

(Hook F). Skell. (Periplocaceae)

42920/HNC

Fruits

Reproduction system [Roots water extract (400 mg/kg/day) for 55 days caused testicular lesions resulting in the cessation of spermatogenesis, degenerative changes in the somniferous tubules and epididymides in rats] [32]

Olax subscorpioidea

Oliv. (Olacaceae)

3528/SRFK

Seeds

Antibacterial and cytotoxic against Artemia salina [Santalbic acid] [33, 34]; Cytotoxicity of leaves crude methanol extract on cancer cells [weak activity on leukemia CCRF-CEM and pancreatic MiaPaCa-2 cell lines and significant activity with IC50 of 10.65 μg/ml on CEM/ADR5000 cells] [27]

Solanum melongena L.Var inerme D.C Hiern. (Solanaceae)

22615/SRFC

Fruits

Antimicrobial activity of methanol, dichloromethane and petrol ether extracts of the fruits: [Q: Tm, Tr, Tt, Ca et Tb [35]

Piper capense

Lin.f (Piperaceae)

7650/SRF-Cam

Fruits

Insecticidal [N-isobutyl-ll-(3, 4-methylenedioxyphenyl)-2E, 4E, 10E-undecatrienamide; N-pyrrolidyl-12-(3, 4-methylene-dioxyphenyl)-2E, 4E, 9E, 11Z-dodecatetraenamide; N-isobutyl-13-(3, 4-methylenedioxyphenyl)-2E, 4E, 12E-tridecatrienamide; N-isobutyl-2E, 4E-decadienamide; N-isobutyl-2E, 4E-dodecadienamide] [36]; Cytotoxicity of fruit crude methanol extract [Significant activity with IC50 values of 7.02; 6.56 and 8.92 μg/ml respectively on leukemia CCRF-CEM cells, CEM/5000 cells and pancreatic MiaPaCa-2 cell lines] [27]

Xylopia aethiopica (Dunal) A. Rich. (Annonaceae)

16419/SRF-Cam

Bark, leaves, roots, seeds

Antimicrobial [volatile oil of seeds] [19]; Antioxidant [volatile oil of seeds] [37]; Cytotoxicity of seeds crude methanol extract [Significant activity with IC50 values of 3.91; 7.4 and 6.86 μg/ml respectively on leukemia CCRF-CEM cells, CEM/5000 cells and pancreatic MiaPaCa-2 cell lines] [27]

Scorodophloeus zenkeri

Harms. (Caesalpinaceae)

44803/SRF-Cam

Bark

Antimicrobial: [2, 4, 5, 7-Tetrathiaoctane; 2, 4, 5, 6, 8-pentathianonane; 2, 3, 4, 6, 8-pentathianonane; 2, 3, 5, 6, 8, 10-hexathiaundecane; 2, 3, 5-trithiahexane 5-oxide; 2, 4, 5, 7-tetrathiaoctane 2-oxide; 2, 3, 5, 7-tetrathiaoctane 3, 3-dioxide; 2, 3, 5-trithiahexane 3, 3-dioxide [38]; Cytotoxicity of bark crude methanol extract on cancer cells [weak activity on leukemia CCRF-CEM and pancreatic MiaPaCa-2 cell lines and significant activity with IC50 of 10.65 μg/ml on CEM/ADR5000 cells] [27]

a(HNC): Cameroon National Herbarium; (SRF): Société des reserves forestières; Cam: Cameroon; b(/): Not reported

c[Screened activity: significant (S: CMI < 100 μg/ml), moderate (M: 100 < CMI ≤ 625 μg/ml), Weak (W: CMI > 625 μg/ml) Q: Qualitative activity based on the determination of inhibition zone [11, 12]. Tm: Trichophyton mentagophytes; Tr: Trichophyton rubrum; Tt: Trichophyton tonsurans Tb: Trichosporon beigelii; Ca: Candida albicans; Ck: Candida krusei; Af: Aspergillus flavus; Bc: Bacillus cereus; Bs: Bacillus subtilis; Ec: Escherichia coli; Kp: Klebsiella pneumoniae; Sa: Staphylococcus aureus; Sf: Streptococcus faecalis.

The air dried and powdered sample (1 kg) from each spice was extracted with methanol (MeOH) for 48 h at room temperature. The extract was then concentrated under reduced pressure to give residues which constituted the crude extracts. They were then kept at 4°C until further use.

Preliminary phytochemical investigations

The major classes of secondary metabolites; alkaloids, anthocyanins, anthraquinones, flavonoids, phenols, saponins, tannins, steroids and triterpenes were screened according to the common phytochemical methods described by Harborne [5] with some modifications. Briefly, for alkaloids (5 mg plant extract in 10 ml methanol); a portion of 2 ml extract + 1% HCl + steam, 1 ml filtrate + 6 drops of Mayor's reagents/Wagner's reagent/Dragendroff reagent; creamish precipitate/brownish-red precipitate/orange precipitate indicated the presence of respective alkaloids. For tannins (5 mg plant extract in 10 ml distilled water); a portion of 2 ml + 2 ml FeCl3; blue-black precipitate indicated the presence of tannins. For saponins (frothing test: 0.5 ml filtrate + 5 ml distilled water); frothing persistence indicated presence of saponins. For steroids and triterpenoids (Liebermann-Burchard reaction: 5 mg plant extract in 10 ml chloroform, filtered); a 2 ml filtrate + 2 ml acetic anhydride + conc. H2SO4. Blue-green ring or pink-purple indicated the presence of steroids or triterpenoids. For flavonoids (5 mg plant extract in 10 ml methanol); a portion of 2 ml + conc. HCl + magnesium; ribbon pink-tomato red color indicated the presence of flavonoids. For anthocyanins (5 mg plant extract in 10 ml methanol); a portion 2 ml + 1%HCl +heating; orange color indicated the presence of anthocyanins. For anthraquinones (5 mg plant extract in 10 ml methanol); a portion of 2 ml + 2 ml ether-chloroform 1:1 v/v + 4 ml NaOH 10% (w/v); red color indicated the presence of anthraquinones. For phenols (5 mg plant material in 10 ml methanol); a portion of 2 ml + 2 ml FeCl3; violet-blue or greenish color indicated the presence of phenols.

Chemicals for antimicrobial assays

Tetracycline (TET), cefepime (FEP), streptomycin (STR), ciprofloxacin (CIP), norfloxacin (NOR), chloramphenicol (CHL), cloxacillin (CLX), ampicillin (AMP), erythromycin (ERY), kanamycin (KAN) (Sigma-Aldrich, St Quentin Fallavier, France) were used as reference antibiotics. p-Iodonitrotetrazolium chloride (INT) and phenylalanine arginine β-naphthylamide (PAßN) were used as microbial growth indicator and efflux pumps inhibitor respectively.

Bacterial strains and culture media

The studied microorganisms included reference (from the American Type Culture Collection) and clinical (Laboratory collection) strains of Providencia stuartii, Pseudomonas aeruginosa, Klebsiella pneumoniae, Escherichia coli, Enterobacter aerogenes and Enterobacter cloacae (Table 2). They were maintained on agar slant at 4°C and sub-cultured on a fresh appropriate agar plates 24 h prior to any antimicrobial test. Mueller Hinton Agar was used for the activation of bacteria. The Mueller Hinton Broth (MHB) was used for the MIC determinations.
Table 2

Bacterial strains and features

Strains

Features

References

Escherichia coli

  

   ATCC8739 and ATCC10536

Reference strains

 

   AG100

Wild-type E. coli K-12

[39]

   AG100A

AG100 ΔacrAB::KANR

[39]

   AG100ATET

ΔacrAB mutant de AG100, avec le gène acrF sur-exprimé; TETR

[39]

   AG102

ΔacrAB mutant AG100, owing acrF gene markedly over-expressed; TETR

[40]

   MC4100

Wild type E. coli

 

   W311O

Wild type E. coli

[41]

Enterobacter aerogenes

  

   ATCC13048

Reference strains

 

   EA-CM64

CHLR resistant variant obtained from ATCC13048 over-expressing the AcrAB pump

[42]

   EA3

Clinical MDR isolate; CHLR, NORR, OFXR, SPXR, MOXR, CFTR, ATMR, FEPR

[42]

   EA27

Clinical MDR isolate exhibiting energy-dependent norfloxacin and chloramphenicol efflux with KANR AMPR NALR STRR TETR

[42, 43]

   EA289

KAN sensitive derivative of EA27

[43, 44]

   EA294

EA289 acrA:: KANR

[44]

   EA298

EA 289 tolC:: KANR

[44]

Enterobacter cloacae

  

   ECCI69

Clinical isolates

Laboratory collection of UNR-MD1, University of Marseille, France

   BM47

Clinical isolates

Laboratory collection of UNR-MD1, University of Marseille, France

   BM67

Clinical isolates

Laboratory collection of UNR-MD1, University of Marseille, France

Klebsiella pneumoniae

  

   ATCC12296

Reference strains

 

   KP55

Clinical MDR isolate, TETR , AMPR, ATMR, CEFR

[45]

   KP63

Clinical MDR isolate, TETR, CHLR, AMPR, ATMR

[45]

   K24

AcrAB-TolC

Laboratory collection of UNR-MD1, University of Marseille, France

   K2

AcrAB-TolC

Laboratory collection of UNR-MD1, University of Marseille, France

Providencia stuartii

  

   NEA16

Clinical MDR isolate, AcrAB-TolC

 

   ATCC29914

Clinical MDR isolate, AcrAB-TolC

[46]

   PS2636

Clinical MDR isolate, AcrAB-TolC

 

   PS299645

Clinical MDR isolate, AcrAB-TolC

 

Pseudemonas aeruginosa

  

   PA 01

Reference strains

 

   PA 124

MDR clinical isolate

[26]

aAMP, ATMR, CEFR, CFTR, CHLR, FEPR, KANR, MOXR, STRR, TETR. Resistance to ampicillin, aztreonam, cephalothin, cefadroxil, chloramphenicol, cefepime, kanamycin, moxalactam, streptomycin, and tetracycline; MDR: Multidrug resistant.

Bacterial susceptibility determinations

The respective MICs of samples on the studied bacteria were determined using rapid INT colorimetric assay [6, 7]. Briefly, the test samples were first dissolved in DMSO/MHB. The solution obtained was then added to MHB, and serially diluted two fold (in a 96-wells microplate). One hundred microlitres (100 μl) of inoculum (1.5 × 106 CFU/ml) prepared in MHB was then added. The plates were covered with a sterile plate sealer, then agitated to mix the contents of the wells using a shaker and incubated at 37°C for 18 h. The final concentration of DMSO was lower than 2.5% and did not affect the microbial growth. Wells containing MHB, 100 μl of inoculum and DMSO at a final concentration of 2.5% served as negative control (this internal control was systematically added). The total volume in each well was 200 μl. Chloramphenicol was used as reference antibiotic. The MICs of samples were detected after 18 h incubation at 37°C, following addition (40 μl) of 0.2 mg/ml INT and incubation at 37°C for 30 minutes. Viable bacteria reduced the yellow dye to pink. MIC was defined as the lowest sample concentration that prevented this change and exhibited complete inhibition of microbial growth [8].

Samples were tested alone and then, in the presence of PAßN at 30 μg/ml final concentration. Two of the best extracts [those from D. glomerata and B. cinnamomea] were also tested in association with antibiotics at MIC/2 and MIC/5. These concentrations were selected following a preliminary assay on one of the tested MDR bacteria, P. aeruginosa PA124 (See Additional file 1, Table A1). All assays were performed in triplicate and repeated thrice. Fractional inhibitory concentration (FIC) was calculated as the ratio of MICAntibiotic in combination/MICAntibiotic alone and the interpretation made as follows: synergistic (< 0.5), indifferent (0.5 to 4), or antagonistic (> 4) [9] (The FIC values available in Additional file 1, Tables A2 and A3).

Results

Phytochemical composition of the spice extracts

The results of the phytochemical studies (Table 3) showed that all the tested extracts contain alkaloids, phenols and tannins. Anthocyanins, anthraquinones, flavonoids, saponins, sterols and triterpenes were selectively present.
Table 3

Extraction yields, aspects and phytochemical composition of the plant extracts.

Spice samples

Extraction yield*

Physical aspect

Phytochemical composition

   

Alkaloids

Anthocyanins

Anthraquinones

Flavonoids

Phenols

Saponins

Tannins

Sterols

Triterpenes

Fagara xanthoxyloides

12.13

Oily brown

+

-

+

+

+

-

+

-

-

Dichrostachys glomerata

18.29

Brown paste

+

+

+

+

+

+

+

+

+

Aframomum citratum

16.32

Brown paste

+

-

-

+

+

+

+

+

-

Beilschmiedia cinnamomea

5.67

Black paste

+

+

+

+

+

-

+

-

+

Echinops giganteus

8.87

Oily brown

+

+

+

+

+

-

+

-

+

Mondia whitei

7.33

Brown paste

+

+

+

+

+

+

+

+

+

Olax subscorpioidea

12.34

Brown paste

+

-

+

+

+

-

+

-

+

Solanum melongena

14.30

Black paste

+

+

+

+

+

+

+

+

+

Piper capense

12.87

Brown paste

+

-

-

-

+

+

+

+

+

Xylopia aethiopica

26.42

Brown paste

+

-

-

-

+

+

+

-

+

Scorodophloeus zenkeri

4.67

Brown paste

+

-

-

-

+

+

+

-

+

(+): Present; (-): Absent; *The yield was calculated as the ratio of the obtained methanol extract according to the initial mass of the spice powder

Antibacterial activity of the spice extracts

The results of the antibacterial activity of the extract alone on a panel of Gram negative bacteria are summarized in Table 4. It appears that the extract from D. glomerata was able to prevent the growth of all the twenty nine tested bacteria with MIC ≤ 1024 μg/ml. All other samples showed selective activity; their inhibitory activity being recorded on 28 of the 29 (96.6%) tested bacteria for B. cinnamomea, 24/29 (82.8%) for A. citratum, 19/29 (62.5%) for P. capense, 18/29 (62.1%) for E. giganteus and F. Xanthoxyloïdes, 15/29 (51.7%) for O. subscorpioïdea, 13/29 (44.8%) for X. aethiopica, 12/29 (41.4%) for M. whitei, 6/29 (20.7%) for S. melongena and 4/29 (13, 79%) for S. zenkeri.
Table 4

Minimal inhibitory concentration (MIC) of the studied spice extracts and CHL on the studied bacterial species.

 

Tested samples and MIC in μg/ml in the absence and presence of PAßN (in parenthesis)

Bacterial strains

F .

xanthoxyloides

D .

glomerata

A .

citratum

B. cinnamomea

E .

giganteus

M .

whitei

S .

melongena

O .

subscorpioidea

P .

capense

X .

aethiopica

S. zenkeri

CHL

E. coli

           

ATCC8739

- (1024)

1024 (512)

1024 (256)

- (256)

- (-)

- (1024)

- (128)

- (-)

- (512)

- (512)

- (-)

4 (< 2)

ATCC10536

1024

512 (128)

1024

1024

1024

1024

-

512

256

64

256

< 2 (< 2)

AG100

256

512 (256)

1024 (1024)

1024 (1024)

1024 (1024)

1024 (-)

1024 (-)

512 (-)

- (1024)

1024 (1024)

- (-)

8 (< 2)

AG100A

1024

1024 (256)

1024

1024

1024

-

-

1024

1024

-

-

< 2 (< 2)

AG100ATET

-

1024 (512)

1024

512

1024

-

-

-

1024

1024

-

64 (< 2)

AG102

1024

512 (256)

1024

512

1024

-

-

1024

1024

1024

-

32 (< 2)

MC4100

256

256(< 8)

512

256

512

1024

1024

1024

1024

1024

-

32

W3110

- (512)

256 (< 8)

512 (< 8)

1024 (< 8)

1024 (1024)

1024 (512)

-

512 (512)

1024 (1024)

- (-)

- (-)

4 (< 2)

E. aerogenes

-

           

ATCC13048

-

512 (512)

1024

512

-

-

-

-

-

-

-

8 (< 2)

CM64

- (-)

512 (512)

- (1024)

1024 (1024)

1024 (1024)

1024 (-)

- (-)

- (-)

- (-)

- (-)

- (-)

256 (8)

EA3

1024

1024 (1024)

-

1024

-

-

-

1024

1024

-

-

- (128)

EA27

1024

512 (256)

1024

1024

1024

1024

-

512

1024

1024

-

256 (< 2)

EA289

-

1024 (1024)

1024

512

1024

-

-

-

-

-

-

- (64)

EA298

-

1024 (128)

-

1024

-

1024

-

256

512

1024

128

64 (< 2)

EA294

256

128

512

64

256

-

1024

256

256

256

512

8

E. cloacae

           

ECCI69

512 (-)

1024 (1024)

1024 (1024)

1024 (512)

1024 (-)

- (-)

- (-)

- (-)

-

-(1024)

- (256)

- (16)

BM47

1024 (1024)

1024 (256)

1024 (1024)

1024 (1024)

1024 (-)

- (-)

- (-)

- (-)

512(64)

1024(1024)

- (-)

- (< 2)

BM67

1024 (1024)

1024 (128)

1024

1024

-

-

-

-

512

1024

-

256 (16)

K. pneumoniae

           

ATCC11296

1024 (1024)

512 (128)

512 (512)

256 (256)

1024 (256)

- (1024)

- (1024)

1024 (512)

1024 (256)

- (-)

- (-)

4 (< 2)

KP55

1024

512 (256)

1024

512

-

-

-

1024

1024

-

-

64 (2)

KP63

1024

512 (< 8)

256

512

512

1024

512

256

256

64

-

64 (< 2)

K24

512

512 (32)

512

256

32

1024

1024

-

1024

-

-

16 (< 2)

K2

-

1024 (128)

-

1024

-

-

-

1024

512

-

-

32 (4)

P. stuartuii

           

NEA16

1024

512 (32)

128

256

1024

1024

1024

512

256

512

1024

32 (8)

ATCC29914

1024

1024 (512)

512

512

1024

1024

-

-

1024

-

-

16 (8)

PS2636

-

512

1024

1024

-

-

-

-

-

-

-

32

PS299645

1024 (-)

256 (256)

256

256 (512)

- (-)

- (-)

- (512)

- (-)

- (-)

- (-)

- (-)

32 (< 2)

P. aeruginosa

           

PA01

-

1024 (512)

1024

1024

-

-

-

-

-

1024

-

16 (< 2)

PA124

-

512 (512)

-

1024

-

1024

-

-

-

-

-

32 (< 2)

(-): MIC not detected at up to 1024 μg/ml for the les extracts and 256 μg/ml for CHL. (): values in parenthesis are MIC of substance in the presence of PAßN at 30 μg/ml. The MIC of PAßN was 64 μg/ml on E. coli, AG100A, 512 μg/ml on ATCC11296, BM67, EA27, EA289; 1024 μg/ml on AG100ATET, ATCC13048, CM64; and > 1024 μg/ml on other bacteria. CHL: chloramphénicol

MIC values below 100 μg/ml (Table 4) were recorded with the extract of B. cinnamomea against Enterobacter aerogenes EA294 (64 μg/ml), E. giganteus on Klebsiella pneumoniae K24 (32 μg/ml) and X. aethiopica on Escherichia coli ATCC10536 and Klebsiella pneumoniae KP63 (64 μg/ml).

Role of efflux pumps in susceptibility of Gram negative bacteria to the tested spice extracts

The various strains and MDR isolates were tested for their susceptibilities to the spice extracts, and reference antibiotic, CHL in the presence of PAßN, a well-known efflux pump inhibitor. The results presented in Table 4 showed that the activity of the extract from D. glomerata significantly increased in the presence of PAßN on 18/26 (69.2%) of the tested bacteria. The MIC values below 100 μg/ml were noted with this extract against E. coli MC4100 and W3110 (< 8 μg/ml), K. pneumoniae KP63 and K24 (< 8 μg/ml and 32 μg/ml respectively) and P. stuartii NAE16 (32 μg/ml). Apart from the extract of D. glomerata, PAßN did not induce an increased activity of other tested extract.

Effects of the association of some spice extracts with antibiotics

To evaluate the possible synergistic effects of the extracts with antibiotics, four of the most active samples (F. xanthoxyloïdes, D. glomerata, B. cinnamomea and O. subscorpioïdea) were selected. A preliminary study using P. aeruginosa PA124, one of the MDR bacteria used in this work, was carried out with ten antibiotics (CLX, AMP, ERY, KAN, CHL, TET, FEP, STR, CIP and NOR) to select the appropriate sub-inhibitory concentrations to be used. The results (see Additional file 1, Table A1) allow the selection of MIC/2 and MIC/5 as the sub-inhibitory concentrations of the extracts from D. glomerata and B. cinnamomea, which were then tested on eight MDR bacteria, E. coli AG100, AG100TET, K. pneumoniae KP55, E. aerogenes EA3, EA27, EA289, CM64 in addition to P. aeruginosa PA124. The results are summarized in Tables 5 and 6. Synergistic effects were observed with the association between D. glomerata (Table 5, Additional file 1, Table A2) and B. cinnamomea ( Table 6, Additional file 1, Table A3) and most of the antibiotics on the studied MDR bacteria. At MIC/2, synergistic effects were noted with the extract of D. glomerata on 25% (2/8) of the tested bacteria for CLX and AMP, 50% (4/8) for KAN, 62.5% (5/8) for CHL, FEP, STR, CIP, 75% (6/8) for ERY and 87.5% (7/8) for NOR and TET. Increase in MIC values of > 8 fold were recorded at MIC/2 with CHL, TET, STR, CIP, NOR (Table 5). At MIC/5, synergistic effects were noted on 50% of the eight tested MDR bacteria in the case of STR and CIP, 62.5% in the case of ERY and 75% in the case of CHL, TET and NOR.
Table 5

Minimal inhibitory concentration (MIC) in μg/ml of antibiotics in the absence and presence of the sub-inhibitory concentrations of D. glomerata extracts against MDR bacteria.

Bacterial strains

Antibiotics and MIC in absence and presence D. glomerata extracts at MIC/2 and MIC/5

 

Chloramphenicol

Cloxacillin

Ampicillin

Erythromycin

Kanamycin

 

Alone

MIC/2

MIC/5

Alone

MIC/2

MIC/5

Alone

MIC/2

MIC/5

Alone

MIC/2

MIC/5

Alone

MIC/2

MIC/5

PA124

32

32 (1) I

16 (2) s

-

-

-

64

-

-

64

32 (2) s

64 (1) I

64

16 (4) s

64 (1)

CM64

256

256 (1) I

-

-

-

-

-

-

256

-

64

128

1

1 (1) I

1(1) I

EA3

-

32 (> 16) s

32 (> 16) s

-

256

256

-

-

-

64

32 (2) s

64 (1) I

32

16 (2) s

16 (2) s

EA27

256

32 (8) s

64 (4) s

256

64 (4) s

64 (4) s

64

64 (1) I

64 (1) I

32

32 (1) I

32 (1) I

16

16 (1) I

16 (1) I

EA289

-

-

-

-

-

-

-

256

64

256

64 (4) s

128 (2) s

4

< 2 (> 2) s

4 (1) I

KP55

64

8 (8) s

16 (4) s

-

-

-

-

-

-

256

128 (2) s

128 (2) s

32

32 (1) I

32 (1) I

AG100ATET

64

8 (8) s

16 (4) s

-

-

-

-

16

32

32

32 (1) I

16 (2) s

32

2 (16) s

8 (4) s

AG100

8

< 2 (> 4) s

< 2 (> 4) s

256

128 (2) s

64 (4) s

64

4 (16) s

4 (16) s

32

< 2 (> 16) s

4 (8) s

< 2

< 2

< 2

Bacterial strains

Tetracycline

Cefepime

Streptomycin

Ciprofloxacin

Norfloxacin

 

Alone

MIC/2

MIC/5

Alone

MIC/2

MIC/5

Alone

MIC/2

MIC/5

Alone

MIC/2

MIC/5

Alone

MIC/2

MIC/5

PA124

4

< 0, 5 (> 8) s

2 (2) s

-

-

-

16

16 (1) I

16 (1) I

16

< 0, 5 (> 8) s

16 (1) I

128

-

-

CM64

32

4 (8) s

8 (4) s

256

64 (4) s

128 (2) s

8

< 2 (> 4) s

4 (2) s

1

1 (1) I

1 (1) I

2

1 (2) s

1 (2) s

EA3

2

1 (2) s

2 (2) s

-

-

-

16

8 (2) s

8 (2) s

64

4 (16) s

64 (1) I

64

32 (2) s

64 (1) I

EA27

16

4 (4) s

8 (2) s

256

128 (2) s

128 (2) s

8

4 (2) s

4 (2) s

2

2 (1) I

2 (1) I

16

2 (8) s

4 (4) s

EA289

8

1 (8) s

2 (4) s

-

256 (> 2) s

-

64

8 (8) s

32 (2) s

32

16 (2) s

16 (2) s

64

16 (4) s

32 (2) s

KP55

4

2 (2) s

2 (2) s

-

128 (> 4) s

-

8

8 (1) I

8 (1) I

128

4 (32) s

32 (4) s

128

32 (4) s

32 (4) s

AG100ATET

4

1 (4) s

2 (2) s

-

32(> 16) s

-

16

2 (8) s

16 (1) I

64

32 (2) s

16 (4) s

64

8 (8) s

16 (4) s

AG100

< 2

< 2 (> 4) s

< 2 (> 4) s

256

< 2 (> 128) s

< 2 (> 128) s

256

256 (1) I

256 (1) I

< 2

< 2

< 2

32

4 (8) s

32 (1) I

MIC/2: concentration of plant extract added equal to 256 μg/ml for PA124, CM64, EA3, EA27, KP55, AG100; and to 512 μg/ml for EA289 and AG100ATET.

MIC/5: concentration of plant extract added equal to 102.4 μg/ml for PA124, CM64, EA3, EA27, KP55, AG100; and to 204.8 μg/ml for EA289 and AG100ATET

(): Values in bracket are folds increase of activity. S: synergy, I: indifference; (-): > 512 μg/ml

Table 6

Minimal inhibitory concentration (MIC) of antibiotics in the absence and presence of the sub-inhibitory concentrations of B. cinnamomea extract (μg/ml) against some MDR bacteria.

Bacterial strains

Antibiotics and MIC in absence and presence B. cinnamomea extracts at MIC/2 and MIC/5

 

Chloramphenicol

Cloxacillin

Ampicillin

Erythromycin

Kanamycin

 

Alone

MIC/2

MIC/5

Alone

MIC/2

MIC/5

Alone

MIC/2

MIC/5

Alone

MIC/2

MIC/5

Alone

MIC/2

MIC/5

PA124

32

< 0, 5 (> 32) s

32 (1) s

-

-

-

-

-

-

64

8 (8) s

32 (2) s

32

32 (1)

64

CM64

256

-

-

-

-

-

-

-

-

-

64 (> 8) s

64 (> 8) s

1

< 0.5 (> 2) s

< 0.5 (> 2) s

EA3

-

16 (> 32) S

32

-

256

-

-

-

-

64

8 (8) s

32 (2) s

32

16 (2) s

16 (2) s

EA27

256

8 (32) s

16 (16) s

256

< 0, 5 (> 512) s

16(16) s

64

64 (1) I

64 (1) I

32

8 (4) s

32 (2) s

16

< 0.5 (> 32) s

16(1) I

EA289

-

256

-

-

-

-

-

-

-

256

32 (8) s

64 (4) s

4

4 (1) I

4 (1) I

KP55

64

8 (8) s

8 (8) s

-

-

-

-

-

-

256

128 (2) s

128 (2) s

32

32 (1) I

32 (1) I

AG100ATET

64

16 (4) s

32 (2) s

-

128 (> 4) S

128 (> 4) S

-

8 (> 64) S

32 (16) S

32

32 (1) I

32 (1) I

32

1 (32) s

8 (4) s

AG100

8

< 2 (> 4) s

4 (2) s

256

256 (1)

256 (1)

64

< 2(> 32) s

4 (16) s

32

< 2 (> 16) s

4 (8) s

< 2

< 2

< 2

Bacterial strains

Tetracycline

Cefepime

Streptomycin

Ciprofloxacin

Norfloxacin

 

Alone

MIC/2

MIC/5

Alone

MIC/2

MIC/5

Alone

MIC/2

MIC/5

Alone

MIC/2

MIC/5

Alone

MIC/2

MIC/5

PA124

4

2 (2) s

4 (1) s

-

64 (> 8) s

-

16

16 (1)

16 (1)

16

16 (1) I

16 (1) I

128

64 (2) s

64 (2) s

CM64

32

8 (4) s

8 (4) s

256

32 (8) s

32 (8) s

8

< 2 (> 4) s

< 2 (> 4) s

1

1 (1) I

1 (1) I

2

1 (2) s

2 (1) I

EA3

2

1 (2) s

2 (1) I

-

-

-

16

4 (4) s

4 (4) s

64

4 (16) s

8(8) s

64

16 (4) s

32 (2) s

EA27

16

1 (16) s

4 (4) s

256

16 (16) s

64(4) s

8

< 0.5 (> 16) s

2 (4) s

2

< 0.5 (> 4) s

2 (1) I

16

< 0.5 (> 32) s

4 (4) s

EA289

8

4 (2) s

4 (2) s

-

256 (> 2) s

256 (> 2) s

64

16 (4) s

64 (1) I

32

16 (2) s

16 (2) s

64

32 (2) s

32 (2) s

KP55

4

4 (1) I

4 (1) I

-

64 (> 8) s

128 (> 2) s

8

8 (1) I

8 (1) I

128

8 (16) s

16 (8) s

128

16 (8) s

32 (4) s

AG100ATET

4

2 (2) s

2 (2) s

-

256 (> 2) s

64(> 4) s

16

8 (2) s

16 (1) I

64

4 (16) s

8 (8) s

64

32 (2) s

64 (1) I

AG100

< 2

< 2

< 2

256

64 (4) s

64 (4) s

256

256 (1) I

256 (1) I

4

< 2 (> 2) s

< 2 (> 2) s

32

4 (8) s

32 (1) I

MIC/2: concentration of plant extract added equal to 512 μg/ml for PA124, CM64, EA3, EA27, AG100; and to 256 μg/ml for EA289, KP55 and AG100ATET

MIC/5: concentration of plant extract added equal to 204.8 μg/ml for PA124, CM64, EA3, EA27, KP55, AG100; and to102.4 μg/ml for EA289 and AG100ATET

(): Values in bracket are folds increase of activity. S: synergy, I: indifference; (-): > 512 μg/ml

The extract of B. cinnamomea at MIC/2 (Table 6) also induced significant increase of the activity of several antibiotics, the synergistic effects being noted on 25% of the tested bacteria in the case of CLX and AMP, 50% in the case of KAN, 62.5% in the case of FEP and STR, 75% in the case of CHL, TET and CIP, 87.5% in the case of ERY and 100% for NOR. With this extract, synergistic effects were also observed at MIC/5 on 25% of the studied MDR bacteria in the case of CLX and AMP, 37.5% in the case of STR and KAN, 50% in the case of TET, 62.5% in the case of CHL, FEP, NOR and CIP and 75% in the case of ERY.

Discussion

Phytochemical composition of the spice extracts

Phytochemical screening revealed the presence of several classes of secondary metabolites. Though the detection of such metabolites does not automatically predict the antimicrobial activity of a plant extract, it has clearly been demonstrated that several compounds belonging to the investigated classes of metabolites showed antibacterial activities [4, 1012].

Antibacterial activity of the spice extract

Phytochemicals are routinely classified as antimicrobials on the basis of susceptibility tests that produce MIC in the range of 100 to 1000 μg/ml [13]. Activity is considered to be significant if MIC values are below 100 μg/ml for crude extract and moderate when 100 < MIC < 625 μg/ml [11]. Therefore, the activity recorded with B. cinnamomea and E. giganteus respectively on E. aerogenes EA294 and K. pneumoniae K24, and X. aethiopica on E. coli ATCC10536 and K. pneumoniae KP63 can be considered significant. Alternative criteria have been described by Fabry et al. [14], which consider extracts having MIC values below 8000 μg/ml to have noteworthy antimicrobial activity. Under these less stringent criteria, and considering the fact that the spices tested are used as food ingredients with limited toxicity, the overall activity recorded with several extracts, most notably those of D. glomerata, B. cinnamomea, A. citratum, P. capense, E. giganteus, F. Xanthoxyloïdes and O. subscorpioïdea, could be considered important. Besides, some of the tested samples were more active than CHL used as reference antibiotic on some of the MDR bacteria such as E. cloacae ECCI69 and BM47, E. aerogenes EA27 and EA289, highlighting the importance of the results reported herein. It can be noted that all the investigated phytochemical classes were detected in the extracts of D. glomerata, S. melongena and M. withei. Contrary to D. glomerata extract that exhibited a good spectrum of activity, the inhibition potential of S. melongena and M. withei was lower and seems not in correlation with their chemical composition. This clearly confirms the fact that the presence of secondary metabolites does not automatically predict the antimicrobial activity of a plant extract though it is a good indication of its possible pharmacological potential.

To the best of our knowledge, the antibacterial activity of B. cinnamomea and P. capense is being reported for the first time. Moreover, the present work reports for the first time the activity of the tested spices on MDR bacteria. Nevertheless, the antimicrobial potential of some of the plants or related genus were demonstrated on sensitive strains. Banso and Adeyemo [15] reported the presence of antibacterial tannins in the genus Dichrostachys. Chouna et al. [16] also demonstrated that Beilschmiedia anacardioides was significantly active against Bacillus subtilis, Micrococcus luteus and Streptococcus faecalis. Plants of the genus Echinops such as E. ellenbeckii and E. longisetus were found active on Staphylococcus aureus[17] meanwhile the antibacterial activity of the essential oils and alkaloids from F. xanthoxyloïdes was also documented [18, 19]. The aqueous and ethanol extracts from O. subscorpioïdea were found active on both bacteria and fungi [20]. The results obtained in the present work therefore provide additional information on the studied plants and are in consistence with some of the previous reports.

Role of efflux pumps in susceptibility of Gram negative bacteria to the tested spice extracts

Tripartite efflux systems, mainly those clinically described as AcrAB-TolC in Enterobacteriaceae or MexAB-OprM in P. aeruginosa, are associated with a major human health problem as they play a central role in multidrug resistance of pathogenic Gram negative bacteria [2123]. PAßN has been reported as a potent inhibitor of the RND efflux systems and is especially active on AcrAB-TolC and MexAB-OprM [22, 24, 25]. To determine the role of efflux pumps in this work, the concentration of PAßN used (30 μg/ml) had no intrinsic effect on the bacteria as previously determined [26]. In contrast, with these conditions significant increase of the antibacterial activity of D. glomerata extract was noted, showing that one or more active compounds from this plant could be substrate(s) of efflux pumps acting in resistant strains of E. coli, K. pneumoniae and P. stuartii. These data suggest that possible association of the extract of D. glomerata and efflux pump inhibitor can be envisaged to improve the fight against MDR phenotypes.

Effects of the association of extracts from D. glomerata and B. cinnamomea with antibiotics

The association of natural products such as plant extracts and antibiotics constitutes an alternative in the fight against MDR bacteria. Significant synergistic effects were noted with both D. glomerata and B. cinnamomea extracts when they were associated with several antibiotics. Such effects might be due either to the action of the active compounds or possible inhibition of the efflux pumps by other compounds of the extracts. The lowest synergistic effects were observed with β-lactamines (CLX and AMP), obviously due to the fact their target are localized in the bacterial cell coat. However, the synergistic effects observed indicate that active compounds of the extract could also present different mode(s) of action from those of the studied antibiotics.

Conclusion

The overall results of the present work provide baseline information for the possible use of the studied spice extracts in the treatment of bacterial infections involving MDR phenotypes. In addition to these antibacterial activities, the data reported herein indicated that possible combinations of the extract of D. glomerata with an efflux pump inhibitor, and also the association of extract of this plant as well as that from B. cinnamomea with several antibiotics could be used in the control of bacterial infections involving MDR phenotypes.

Declarations

Acknowledgements

Authors are thankful to the Cameroon National Herbarium (Yaounde) for plants identification and Mr. Paul K. Lunga and Dr Gerald Ngo Teke for language editing.

Authors’ Affiliations

(1)
Department of Biochemistry, Faculty of science, University of Dschang
(2)
Transporteurs Membranaires, Chimiorésistance et Drug Design, UMR-MD1, IFR 88, UFRs de Médecine et de Pharmacie

References

  1. Kamicker BJ, Sweeney MT, Kaczmarek F, Dib-Hajj F, Shang W, Crimin K, Duignan J, Gootz TD: Bacteria efflux pomp inhibitors. Methods Mol Med. 2008, 142: 187-204. 10.1007/978-1-59745-246-5_15.View ArticlePubMedGoogle Scholar
  2. Lutz JK, Lee J: Prevalence and Antimicrobial-Resistance of Pseudomonas aeruginosa in Swimming Pools and Hot Tubs. Int J Environ Res Public Health. 2011, 8: 554-564. 10.3390/ijerph8020554.View ArticlePubMedPubMed CentralGoogle Scholar
  3. Sofowora A: 1993. Medicinal Plants and Traditional Medicine in Africa. 1993, Ibadan, Spectrum Books LimitedGoogle Scholar
  4. Cowan MM: Plant products as antimicrobial agents. Clinical Microbiology Reviews. 1999, 12: 564-582.PubMedPubMed CentralGoogle Scholar
  5. Harborne JB: Phytochemical Methods. 1973, New York, Chapman and HallGoogle Scholar
  6. Eloff JN: A sensitive and quick microplate method to determine the minimal inhibitory concentration of plant extracts for bacteria. Planta Med. 1998, 64: 711-713. 10.1055/s-2006-957563.View ArticlePubMedGoogle Scholar
  7. Mativandlela SPN, Lall N, Meyer JJM: Antifungal and antitubercular activity of (the roots of) Pelargonium reniforme (CURT) and Pelargonium sidoides (DC) (Geraniaceae) root. S Afr J Bot. 2006, 72: 232-237. 10.1016/j.sajb.2005.08.002.View ArticleGoogle Scholar
  8. Kuete V, Ngameni B, Fotso Simo CC, Kengap Tankeu R, Tchaleu Ngadjui B, Meyer JJM, Lall N, Kuiate JR: Antimicrobial activity of the crude extracts and compounds from Ficus chlamydocarpa and Ficus cordata (Moraceae). J Ethnopharmacol. 2008, 120: 17-24. 10.1016/j.jep.2008.07.026.View ArticlePubMedGoogle Scholar
  9. Coutinho HD, Vasconcellos A, Freire-Pessôa HL, Gadelha CA, Gadelha TS, Almeida-Filho GG: Natural products from the termite Nasutitermes corniger lower aminoglycoside minimum inhibitory concentrations. Pharmacogn Mag. 2010, 6: 1-4. 10.4103/0973-1296.59958.View ArticlePubMedPubMed CentralGoogle Scholar
  10. Bruneton J: Pharmacognosie: Phytochimie, Plantes medicinales. 1999, Paris, Tec & Doc, 263-309. 3Google Scholar
  11. Kuete V: Potential of Cameroonian plants and derived-products against microbial infections: A review. Planta Med. 2010, 76: 1479-1491. 10.1055/s-0030-1250027.View ArticlePubMedGoogle Scholar
  12. Kuete V, Efferth T: Cameroonian medicinal plants: Pharmacology and derived natural products. Front Pharmacol. 2010, 1: 1-19.View ArticleGoogle Scholar
  13. Simões M, Bennett RN, Rosa EA: Understanding antimicrobial activities of phytochemicals against multidrug resistant bacteria and biofilms. Nat Prod Rep. 2009, 26: 746-757. 10.1039/b821648g.View ArticlePubMedGoogle Scholar
  14. Fabry W, Okemo PO, Ansorg R: Antibacterial activity of East African medicinal plants. J Ethnopharmacol. 1998, 60: 79-84. 10.1016/S0378-8741(97)00128-1.View ArticlePubMedGoogle Scholar
  15. Banso A, Adeyemo SO: Evaluation of antibacterial properties of tannins isolated from Dichrostachys cinerea. Afr J Biotech. 2007, 6: 1785-1787.Google Scholar
  16. Chouna JR, Nkeng-Efouet PA, Lenta BN, Devkota PK, Neumann B, Stammler HG, Kimbu SF, Sewald N: Antibacterial endiandric acid derivatives from Beilschmiedia anacardioides. Phytochemistry. 2009, 70: 684-688. 10.1016/j.phytochem.2009.02.012.View ArticlePubMedGoogle Scholar
  17. Hymete A, Iversena TH, Rohloff J, Erkob B: Screening of Echinops ellenbeckii and Echinops longisetus for biological activities and chemical constituents. Phytomedicine. 2005, 12: 675-679. 10.1016/j.phymed.2004.01.013.View ArticlePubMedGoogle Scholar
  18. Chaaib F, Queiroz EF, Ndjoko K, Diallo D, Hostettmann K: Antifungal and antioxidant compounds from the root bark of Fagara zanthoxyloides. Planta Med. 2003, 64: 616-320.Google Scholar
  19. Tatsadjieu LN, Essia Ngang JJ, Ngassoum MB, Etoa FX: Antibacterial and antifungal activity of Xylopia aethiopica, Monodora myristica, Zanthoxylum xanthoxyloides and Zanthoxylum leprieurii from Cameroon. Fitoterapia. 2003, 74: 469-472. 10.1016/S0367-326X(03)00067-4.View ArticlePubMedGoogle Scholar
  20. Ayandele AA, Adebiyi AO: The phytochemical analysis and antimicrobial screening of extracts of Olax subscorpioïdea. Afr J Biotech. 2007, 6: 868-870.Google Scholar
  21. Blot S, Depuydt P, Vandewoude K, De Bacquer D: Measuring the impact of multidrug resistance in nosocomial infection. Curr Opin Infect Dis. 2007, 20: 391-396. 10.1097/QCO.0b013e32818be6f7.View ArticlePubMedGoogle Scholar
  22. Pietras A, Bavro VN, Furnham N, Pellegrini-Calace M, Milner-White EJ, Luisi BF: Structure and mechanism of drug efflux machinery in Gram negative bacteria. Curr Drug Target. 2008, 9: 719-728. 10.2174/138945008785747743.View ArticleGoogle Scholar
  23. Papadopoulos CJ, Carson CF, Chang BJ, Riley TV: Role of the MexAB-OprM efflux pump of Pseudomonas aeruginosa in tolerance to tea tree (Melaleuca alternifolia) oil and its monoterpene components terpinen-4-ol, 1, 8-cineole and α-terpineol. Appl Environ Microbiol. 2008, 74: 1932-1935. 10.1128/AEM.02334-07.View ArticlePubMedPubMed CentralGoogle Scholar
  24. Lomovskaya O, Bostian KA: Practical applications and feasibility of efflux pump inhibitors in the clinic--a vision for applied use. Biochem Pharmacol. 2006, 71: 910-918. 10.1016/j.bcp.2005.12.008.View ArticlePubMedGoogle Scholar
  25. Pagès J-M, Lavigne JP, Leflon-Guibout V, Marcon E, Bert F, Noussair L, Nicolas-Chanoine MH: Efflux Pump, the Masked Side of β-Lactam Resistance in Klebsiella pneumoniae Clinical Isolates. PLoS ONE. 2009, 4: e4817-10.1371/journal.pone.0004817.View ArticlePubMedPubMed CentralGoogle Scholar
  26. Lorenzi V, Muselli A, Bernardini AF, Berti L, Pagès JM, Amaral L, Bolla JM: Geraniol restores antibiotic activities against multidrug-resistant isolate from Gram-negative species. Antimicrob Agents Chemother. 2009, 53: 2209-2211. 10.1128/AAC.00919-08.View ArticlePubMedPubMed CentralGoogle Scholar
  27. Kuete V, Krusche B, Youns M, Voukeng I, Fankam AG, Tankeo S, Lacmata S, Efferth T: Cytotoxicity of some Cameroonian spices and selected medicinal plant extracts. J Ethnopharmacol. 2011, 134: 803-812. 10.1016/j.jep.2011.01.035.View ArticlePubMedGoogle Scholar
  28. Kojima H, Sato N, Hatano A, Ogura H: Sterol glucosides from Prunella vulgaris. Phytochemistry. 1990, 29: 2351-2355. 10.1016/0031-9422(90)83073-A.View ArticleGoogle Scholar
  29. Tane P, Bergquist K-E, Tene M, Ngadjui BT, Ayafor JF, Sterner O: Cyclodione, an unsymmetrical dimeric diterpene from Cylicodiscus gabunensis. Tetrahedron. 1995, 51: 11595-11600. 10.1016/0040-4020(95)00720-S.View ArticleGoogle Scholar
  30. Kuete V, Eyong KO, Folefoc GN, Beng VP, Hussain H, Krohn K, Nkengfack AE: Antimicrobial activity of the methanolic extract and of the chemical constituents isolated from Newbouldia laevis. Pharmazie. 2007, 62: 552-556.PubMedGoogle Scholar
  31. Kuete V, Wansi JD, Mbaveng AT, Kana Sop MM, Tcho Tadjong A, Beng VP, Etoa FX, Wandji J, Marion Meyer JJ, Lall N: Antimicrobial activity of the methanolic extract and compounds from Teclea afzelii (Rutaceae). S Afr J Bot. 2008, 74: 572-576. 10.1016/j.sajb.2008.02.004.View ArticleGoogle Scholar
  32. Watcho P, Kamtchouing P, Sokeng S, Moundipa PF, Tantchou J, Essame JL, Koueta N: Reversible antispermatogenic and antifertility activities of Mondia whitei L. in male albino rat. Phytother Res. 2001, 15: 26-29. 10.1002/1099-1573(200102)15:1<26::AID-PTR679>3.0.CO;2-N.View ArticlePubMedGoogle Scholar
  33. Jones GP, Rao KS, Tucker DJ, Richardson B, Barnes A, Rivett DE: Antimicrobial activity of santalbic acid from the oil of Santalum acuminatum (Quandong). Int J Pharmacogn. 1995, 33: 120-123. 10.3109/13880209509055210.View ArticleGoogle Scholar
  34. Cantrell CL, Berhow MA, Phillips BS, Duval SM, Weisleder D, Vaughn SF: Bioactive crude plant seed extracts from the NCAUR oilseed repository. Phytomedicine. 2003, 10: 325-333. 10.1078/094471103322004820.View ArticlePubMedGoogle Scholar
  35. Das J, Lahan JP, Srivastava RB: Solanum melongena: A potential source of antifungal agent. Indian J Microbiol. 2008, 50: 62-69.View ArticleGoogle Scholar
  36. Gbewonyo WSK, Candy DJ: Chromatographic isolation of insecticidal amides from Piper guineense roots. J Chromatogr A. 1992, 607: 105-111. 10.1016/0021-9673(92)87059-H.View ArticleGoogle Scholar
  37. N'dri K, Bosson KA, Mamyrbekova-Bekro JA, Jean N, Bekro YA: Chemical composition and antioxidant activities of essential. EurJ Sci Res. 2009, 37: 311-318.Google Scholar
  38. Kouokam JC, Jahns T, Becker H: Antimicrobial activity of the essential oil and some isolated sulfur-rich compounds from Scorodophloeus zenkeri. Planta Med. 2002, 68: 1082-1087. 10.1055/s-2002-36341.View ArticlePubMedGoogle Scholar
  39. Viveiros M, Jesus A, Brito M, Leandro C, Martins M, Ordway D, Molnar M, Molnar J, Amaral L: Inducement and Reversal of Tetracycline Resistance in Escherichia coli K-12 and Expression of Proton Gradient-Dependent Multidrug Efflux Pump Genes. Antimicrob Agents Chemother. 2005, 49: 3578-3582. 10.1128/AAC.49.8.3578-3582.2005.View ArticlePubMedPubMed CentralGoogle Scholar
  40. Elkins CA, Mullis LB: Substrate competition studies using whole-cell with the major tripartite multidrug efflux pumps of Escherichia coli. Antimicrob Agents Chemother. 2007, 51: 923-929. 10.1128/AAC.01048-06.View ArticlePubMedPubMed CentralGoogle Scholar
  41. Baglioni P, Bini L, Liberatori S, Pallini V, Marri L: Proteome analysis of Escherichia coli W3110 expressing an heterologous sigma factor. Proteomics. 2003, 3: 1060-1065. 10.1002/pmic.200300403.View ArticlePubMedGoogle Scholar
  42. Ghisalberti D, Masi M, Pagès J-M, Chevalier J: Chloramphenicol and expression of multidrug efflux pump in Enterobacter aerogenes. Biochem Biophys Res Commun. 2005, 328: 1113-1118. 10.1016/j.bbrc.2005.01.069.View ArticlePubMedGoogle Scholar
  43. Malléa M, Mahamoud A, Chevalier J, Alibert-Franco S, Brouant P, Barbe J, Pagès JM: Alkylaminoquinolines inhibit the bacterial antibiotic efflux pump in multidrug-resistant clinical isolates. Biochem J. 2003, 376: 801-805. 10.1042/BJ20030963.View ArticlePubMedPubMed CentralGoogle Scholar
  44. Pradel E, Pagès J-M: The AcrAB-TolC efflux pump contributes to multidrug resistance in the nosocomial pathogen Enterobacter aerogenes. Antimicrob Agents Chemother. 2002, 46: 2640-2644. 10.1128/AAC.46.8.2640-2643.2002.View ArticlePubMedPubMed CentralGoogle Scholar
  45. Chevalier J, Pagès J-M, Eyraud A, Malléa M: Membrane permeability modifications are involved in antibiotic resistance in Klebsiella pneumoniae. Biochem Biophys Res Commun. 2000, 274: 496-499. 10.1006/bbrc.2000.3159.View ArticlePubMedGoogle Scholar
  46. Tran QT, Mahendra KR, Hajjar A, Ceccarelli M, Davin-Regli A, Winterhalter M, Weingart H, Pagès JM: Implication of Porins in β-Lactam Resistance of Providencia stuartii. J Biol Chem. 2000, 285: 32273-32281.View ArticleGoogle Scholar
  47. Pre-publication history

    1. The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1472-6882/11/104/prepub

Copyright

© Fankam et al; licensee BioMed Central Ltd. 2011

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Advertisement